GSK Will Focus on Elderly in Trial to Treat Pneumonia From COVID GSK Will Focus on Elderly in Trial to Treat Pneumonia From COVID

GlaxoSmithKline will extend a trial testing an experimental rheumatoid arthritis drug on patients suffering from COVID-related pneumonia in order to focus on the elderly.Reuters Health Information
Source: Medscape Orthopaedics Headlines - Category: Orthopaedics Tags: Pulmonary Medicine News Source Type: news